National Bank of Canada’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $377K | Sell |
2,981
-494
| -14% | -$62.5K | ﹤0.01% | 1184 |
|
2025
Q1 | $444K | Sell |
3,475
-369
| -10% | -$47.1K | ﹤0.01% | 1098 |
|
2024
Q4 | $508K | Sell |
3,844
-280
| -7% | -$37K | ﹤0.01% | 1127 |
|
2024
Q3 | $600K | Buy |
4,124
+229
| +6% | +$33.3K | ﹤0.01% | 1024 |
|
2024
Q2 | $533K | Buy |
3,895
+324
| +9% | +$44.3K | ﹤0.01% | 1042 |
|
2024
Q1 | $476K | Buy |
3,571
+184
| +5% | +$24.5K | ﹤0.01% | 1088 |
|
2023
Q4 | $467K | Sell |
3,387
-285
| -8% | -$39.3K | ﹤0.01% | 1137 |
|
2023
Q3 | $441K | Sell |
3,672
-1,153
| -24% | -$139K | ﹤0.01% | 1171 |
|
2023
Q2 | $612K | Buy |
4,825
+7
| +0.1% | +$888 | ﹤0.01% | 1125 |
|
2023
Q1 | $623K | Sell |
4,818
-674
| -12% | -$87.1K | ﹤0.01% | 1068 |
|
2022
Q4 | $721K | Sell |
5,492
-1,875
| -25% | -$246K | ﹤0.01% | 1059 |
|
2022
Q3 | $861K | Sell |
7,367
-3,146
| -30% | -$368K | ﹤0.01% | 900 |
|
2022
Q2 | $1.24M | Buy |
10,513
+163
| +2% | +$19.2K | 0.01% | 796 |
|
2022
Q1 | $1.28M | Buy |
10,350
+509
| +5% | +$63K | ﹤0.01% | 853 |
|
2021
Q4 | $1.5M | Buy |
+9,841
| New | +$1.5M | 0.01% | 774 |
|